Sacubitril Hemicalcium
沙库比曲半钙盐 | Sacubitril Hemicalcium | 1369773-39-6 | In-House |
沙库比曲钠盐 | 149690-05-1 | In-House | |
LCZ-4 | 1426129-50-1 | In-House | |
LCZ-7 | 1012341-48-8 | In-House | |
LCZ-8 | 1012341-50-2 | In-House | |
LCZ-9 | 149690-12-0 | In-House |
Background
AHU-377 hemicalcium salt is a hemicalcium salt form of AHU-377. It is an inhibitor of neprilysin with IC50 value of 5 nM [1].
AHU-377 and the angiotensin II AT1 receptor antagonist valsartan compose LCZ696 in a 1:1 molar ratio. LCZ696 is an angiotensin receptor neprilysin inhibitor. It can reduce blood pressure and may be a novel drug for the treatment of heart failure. AHU-377 is a pro-drug, it can be converted by enzymatic cleavage of the ethyl ester into the active form LBQ657. It is reported that AHU-377(30 and 100 mg/kg, PO) can cause antihypertensive effect in a dose-dependent manner in DAHI-SS rats. But in the DOCA-salt hypertensive rats, it shows a weak reduction [2, 3].
References:
[1] Ksander GM, Ghai RD, deJesus R, Diefenbacher CG, Yuan A, Berry C, Sakane Y, Trapani A. Dicarboxylic acid dipeptide neutral endopeptidase inhibitors. J Med Chem. 1995 May 12; 38(10):1689-700.
[2] Voors AA, Dorhout B, van der Meer P. The potential role of valsartan + AHU377 ( LCZ696 ) in the treatment of heart failure. Expert Opin Investig Drugs. 2013 Aug;22(8):1041-7.
[3] Laxminarayan G Hegde, Cecile Yu, Cheruvu Madhavi et al. Comparative efficacy of AHU-377, a potent neprilysin inhibitor, in two rat models of volume-dependent hypertension. BMC Pharmacology 2011, 11(Suppl 1):P33.
Chemical structure
![2018 GMP-2](http://www.cz-pharma.com/uploads/beaa7119.jpg)
![原料药GMP证书201811(captopril ,thalidomide etc)](http://www.cz-pharma.com/uploads/15b802ef.jpg)
![GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co](http://www.cz-pharma.com/uploads/40ac545a.jpg)
![FDA-EIR-Letter-201901](http://www.cz-pharma.com/uploads/FDA-EIR-Letter-201901.jpg)
![Quality management1](http://www.cz-pharma.com/uploads/Quality-management1.png)
Proposal 18 Quality Consistency Evaluation projects which have approved 4, and 6 projects are under approving.
![Quality management2](http://www.cz-pharma.com/uploads/Quality-management2.png)
Advanced international quality management system has laid solid foundation for sales.
![Quality management3](http://www.cz-pharma.com/uploads/Quality-management3.png)
Quality supervision runs through the whole life cycle of the product to ensure the quality and therapeutic effect.
![Quality management4](http://www.cz-pharma.com/uploads/Quality-management4.png)
Professional Regulatory Affairs team supports the quality demands during the application and registration.
![cpf5](http://www.cz-pharma.com/uploads/cpf5.png)
![cpf6](http://www.cz-pharma.com/uploads/cpf6.png)
Korea Countec Bottled Packaging Line
![cpf7](http://www.cz-pharma.com/uploads/cpf7.png)
![cpf8](http://www.cz-pharma.com/uploads/cpf8.png)
Taiwan CVC Bottled Packaging Line
![cpf9](http://www.cz-pharma.com/uploads/cpf9.png)
![cpf10](http://www.cz-pharma.com/uploads/cpf10.png)
Italy CAM Board Packaging Line
![cpf11](http://www.cz-pharma.com/uploads/cpf11.png)
German Fette Compacting Machine
![cpf12](http://www.cz-pharma.com/uploads/cpf12.png)
Japan Viswill Tablet Detector
![cpf14-1](http://www.cz-pharma.com/uploads/cpf14-1.png)
DCS Control Room
![International cooperation](http://www.cz-pharma.com/uploads/International-cooperation.jpg)
![Domestic cooperation](http://www.cz-pharma.com/uploads/Domestic-cooperation.jpg)